MB Diagnostics ApS: Financial statements 2022
CVR: 38185853
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MB Diagnostics ApS (CVR 38185853) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 14,655 and a net result of DKK -2,383 compared with DKK 21,690 the year before. That is a decrease of 65.9% compared with the year before. Equity in the 2022 report amounted to DKK 712,844. The solvency ratio was 61.2%.
- Gross Profit
- DKK 14,655
- Profit/Loss
- DKK -2,383
- Equity
- DKK 712,844
- Total Assets
- DKK 1,164,983
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 15 t. | -2 t. | 713 t. | 0 |
| 2021 | - | 43 t. | 22 t. | 828 t. | 0 |
| 2020 | - | -9 t. | -20 t. | 807 t. | 0 |
| 2019 | - | 586 t. | 448 t. | 827 t. | 0 |
| 2018 | - | 645 t. | 491 t. | 379 t. | 0 |
Official annual report
Keep an eye on MB Diagnostics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MB Diagnostics ApS has published its annual report for 2021. Gross profit came to DKK 42,932, and the net result was DKK 21,690.
About MB Diagnostics ApS
MB Diagnostics ApS is a Danish company of the type Anpartsselskab based in Nærum, founded in 2016. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Mikael Ploug Boesen. The company is owned by Mikael Ploug Boesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629.